WASHINGTON, DC — In response to the Congressional Budget Office’s (CBO) score on H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now, issued the following statement:
“H.R. 3 will help fix our broken system and ensure Americans with private and public insurance get the drugs they need at lower prices.
“CBO confirmed the bill will put $456 billion in savings from lower drug prices to work for taxpayers. America’s seniors will benefit from new dental, hearing, and vision coverage, investments in innovative new drugs, and lower out-of-pocket costs.
“H.R. 3’s investment into the world-class research at the National Institutes of Health will more than offset the prediction of about two new drugs lost per year. As a patient whose life is completely dependent on new drugs, I’m confident innovation is protected under this landmark legislation.
“It’s time to pass H.R. 3.”